Report says drugmakers impose unjustified U.S. price increases; spending on AbbVie drug rises $1.4 billion<blockquote>报告称制药商在美国不合理地涨价;艾伯维药物支出增加14亿美元</blockquote>
Netease jumped over 5% in premarket trading as the company will repurchase up to 3 billion US dollars of shares<blockquote>网易盘前涨超5%公司将回购至多30亿美元股票</blockquote>